Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

1293. Keetch DW, Catalona WJ (1995).
Prostatic transition zone biopsies in men
with previous negative biopsies and persistently
elevated serum prostate specific antigen
values. J Urol 154: 1795-1797.
1294. Keetch DW, Humphrey P, Stahl D,
Smith DS, Catalona WJ (1995).
Morphometric analysis and clinical followup
of isolated prostatic intraepithelial
neoplasia in needle biopsy of the prostate. J
Urol 154: 347-351.
1295. Kellert E (1959). An ovarian type
pseudomucinous cystadenoma in the scrotum.
Cancer 12: 187-190.
1296. Kellie SJ, Pui CH, Murphy SB (1989).
Childhood non-Hodgkin’s lymphoma involving
the testis: clinical features and treatment
outcome. J Clin Oncol 7: 1066-1070.
1297. Kempton CL, Kurtin PJ, Inwards DJ,
Wollan P, Bostwick DG (1997). Malignant
lymphoma of the bladder: evidence from 36
cases that low-grade lymphoma of the
MALT-type is the most common primary
bladder lymphoma. Am J Surg Pathol 21:
1324-1333.
1298. Kennedy SM, Merino MJ, Linehan
WM, Roberts JR, Robertson CN, Neumann
RD (1990). Collecting duct carcinoma of the
kidney. Hum Pathol 21: 449-456.
1299. Kennelly MJ, Grossman HB, Cho KJ
(1994). Outcome analysis of 42 cases of
renal angiomyolipoma. J Urol 152: 1988-
1991.
1300. Kerley SW, Blute ML, Keeney GL
(1991). Multifocal malignant melanoma arising
in vesicovaginal melanosis. Arch Pathol
Lab Med 115: 950-952.
1301. Kersemaekers AM, Mayer F, Molier M,
van Weeren PC, Oosterhuis JW, Bokemeyer
C, Looijenga LH (2002). Role of P53 and
MDM2 in treatment response of human
germ cell tumors. J Clin Oncol 20: 1551-1561.
1302. Keshet E, Lyman SD, Williams DE,
Anderson DM, Jenkins NA, Copeland NG,
Parada LF (1991). Embryonic RNA expression
patterns of the c-kit receptor and its
cognate ligand suggest multiple functional
roles in mouse development. EMBO J 10:
2425-2435.
1303. Khalbuss WE, Hossain M, Elhosseiny
A (2001). Primary malignant melanoma of
the urinary bladder diagnosed by urine
cytology: a case report. Acta Cytol 45: 631-
635.
1304. Khan A, Thomas N, Costello B, Jobling
L, de Kretser D, Broadfield E, O’Shea S
(2000). Renal medullary carcinoma: sonographic,
computed tomography, magnetic
resonance and angiographic findings. Eur J
Radiol 35: 1-7.
1305. Khanna S (1991). Cavernous haemangioma
of the glans penis. Br J Urol 67: 332.
1306. Khoo SK, Bradley M, Wong FK,
Hedblad MA, Nordenskjold M, Teh BT
(2001). Birt-Hogg-Dube syndrome: mapping
of a novel hereditary neoplasia gene to
chromosome 17p12-q11.2. Oncogene 20:
5239-5242.
1307. Khoo SK, Giraud S, Kahnoski K, Chen
J, Motorna O, Nickolov R, Binet O, Lambert
D, Friedel J, Levy R, Ferlicot S, Wolkenstein
P, Hammel P, Bergerheim U, Hedblad MA,
Bradley M, Teh BT, Nordenskjold M,
Richard S (2002). Clinical and genetic studies
of Birt-Hogg-Dube syndrome. J Med
Genet 39: 906-912.
1308. Khoo SK, Kahnoski K, Sugimura J,
Petillo D, Chen J, Shockley K, Ludlow J,
Knapp R, Giraud S, Richard S, Nordenskjold
M, Teh BT (2003). Inactivation of BHD in sporadic
renal tumors. Cancer Res 63: 4583-
4587.
1309. Khoury JM, Stutzman RE, Sepulveda
RA (1985). Inverted papilloma of the bladder
with focal transitional cell carcinoma:
a case report. Mil Med 150: 562-563.
1310. Kibel A, Iliopoulos O, Decaprio JA,
Kaelin WGJr (1995). Binding of the von
Hippel-Lindau tumor suppressor protein to
Elongin B and C. Science 269: 1444-1446.
1311. Kidd JM (1970). Exclusion of certain
renal neoplasms from the category of
Wilms tumor. Am J Pathol 58: 16A.
1312. Kiemeney LA, Moret NC, Witjes JA,
Schoenberg MP, Tulinius H (1997). Familial
transitional cell carcinoma among the
population of Iceland. J Urol 157: 1649-
1651.
1313. Kiemeney LA, Schoenberg M (1996).
Familial transitional cell carcinoma. J Urol
156: 867-872.
1314. Kiemeney LA, Witjes JA, Heijbroek
RP, Verbeek AL, Debruyne FM (1993).
Predictability of recurrent and progressive
disease in individual patients with primary
superficial bladder cancer. J Urol 150: 60-
64.
1315. Kilicaslan I, Gulluoglu MG, Dogan O,
Uysal V (2000). Intraglomerular microlesions
in renal angiomyolipoma. Hum
Pathol 31: 1325-1328.
1316. Kim DH, Sohn JH, Lee MC, Lee G,
Yoon GS, Hashimoto H, Sonobe H, Ro JY
(2000). Primary synovial sarcoma of the
kidney. Am J Surg Pathol 24: 1097-1104.
1317. Kim ED, Kroft S, Dalton DP (1994).
Basal cell carcinoma of the penis: case
report and review of the literature. J Urol
152: 1557-1559.
1318. Kim I, Young RH, Scully RE (1985).
Leydig cell tumors of the testis. A clinicopathological
analysis of 40 cases and
review of the literature. Am J Surg Pathol
9: 177-192.
1319. Kim MJ, Bhatia-Gaur R, Banach-
Petrosky WA, Desai N, Wang Y, Hayward
SW, Cunha GR, Cardiff RD, Shen MM,
Abate-Shen C (2002). Nkx3.1 mutant mice
recapitulate early stages of prostate carcinogenesis.
Cancer Res 62: 2999-3004.
1320. Kim SI, Kwon SM, Kim YS, Hong SJ
(2002). Association of cyclooxygenase-2
expression with prognosis of stage T1
grade 3 bladder cancer. Urology 60: 816-
821.
1321. Kim TS, Seong DH, Ro JY (2001).
Small cell carcinoma of the ureter with
squamous cell and transitional cell carcinomatous
components associated with
ureteral stone. J Korean Med Sci 16: 796-
800.
1322. Kindblom LG, Pettersson G (1976).
Primary carcinoma of the seminal vesicle.
Case report. Acta Pathol Microbiol Scand
[A] 84: 301-305.
1323. Kirkland KL, Bale PM (1967). A cystic
adenoma of the prostate. J Urol 97: 324-
327.
1324. Kirsch AJ, Newhouse J, Hibshoosh
H, O’Toole K, Ritter J, Benson MC (1996).
Giant multilocular cystadenoma of the
prostate. Urology 48: 303-305.
1325. Kitamura H, Umehara T, Miyake M,
Shimizu T, Kohda K, Ando M (1996).
NonHodgkin’s lymphoma arising in the
urethra of a man. J Urol 156: 175-176.
1326. Kitamura M, Miyanaga T, Hamada M,
Nakata Y, Satoh Y, Terakawa T (1997).
Small cell carcinoma of the kidney: case
report. Int J Urol 4: 422-424.
1327. Kittredge WE, Collett AJ, Morgan C
(1964). Adenocarcinoma of the bladder
associated with cystitis glandularis. A
case report. J Urol 91: 145-150.
1328. Kiuru M (2002). Molecular basis of
hereditary leiomyomatosis and renal cell
cancer (HLRCC).
1329. Kiuru M, Launonen V, Hietala M,
Aittomaki K, Vierimaa O, Salovaara R, Arola
J, Pukkala E, Sistonen P, Herva R, Aaltonen
LA (2001). Familial cutaneous leiomyomatosis
is a two-hit condition associated
with renal cell cancer of characteristic
histopathology. Am J Pathol 159: 825-829.
1330. Kiuru M, Lehtonen R, Arola J,
Salovaara R, Jarvinen H, Aittomaki K,
Sjoberg J, Visakorpi T, Knuutila S, Isola J,
Delahunt B, Herva R, Launonen V, Karhu A,
Aaltonen LA (2002). Few FH mutations in
sporadic counterparts of tumor types
observed in hereditary leiomyomatosis and
renal cell cancer families. Cancer Res 62:
4554-4557.
1331. Kiyosawa T, Umebayashi Y,
Nakayama Y, Soeda S (1995). Hereditary
multiple glomus tumors involving the glans
penis. A case report and review of the literature.
Dermatol Surg 21: 895-899.
1332. Klan R, Loy V, Huland H (1991).
Residual tumor discovered in routine second
transurethral resection in patients
with stage T1 transitional cell carcinoma of
the bladder. J Urol 146: 316-318.
1333. Klein EA (1993). Tumor markers in
testis cancer. Urol Clin North Am 20: 67-73.
1334. Klein FA, Herr HW, Vugrin D (1983).
Fibrosarcoma associated with intensive
chemotherapy for advanced germ cell testicular
tumor. J Surg Oncol 23: 5-7.
1335. Klein MJ, Valensi QJ (1976). Proximal
tubular adenomas of kidney with so-called
oncocytic features. A clinicopathologic
study of 13 cases of a rarely reported neoplasm.
Cancer 38: 906-914.
1336. Knezevich SR, Garnett MJ, Pysher
TJ, Beckwith JB, Grundy PE, Sorensen PH
(1998). ETV6-NTRK3 gene fusions and trisomy
11 establish a histogenetic link
between mesoblastic nephroma and congenital
fibrosarcoma. Cancer Res 58: 5046-
5048.
1337. Knezevich SR, McFadden DE, Tao W,
Lim JF, Sorensen PH (1998). A novel ETV6-
NTRK3 gene fusion in congenital fibrosarcoma.
Nat Genet 18: 184-187.
1338. Knoll LD, Segura JW, Scheithauer
BW (1986). Leiomyoma of the bladder. J
Urol 136: 906-908.
1339. Knowles MA (1995). Molecular
genetics of bladder cancer. Br J Urol 75
Suppl 1: 57-66.
1340. Knowles MA (2001). What we could
do now: molecular pathology of bladder
cancer. Mol Pathol 54: 215-221.
1341. Knowles MA, Williamson M (1993).
Mutation of H-ras is infrequent in bladder
cancer: confirmation by single-strand conformation
polymorphism analysis,
designed restriction fragment length polymorphisms,
and direct sequencing. Cancer
Res 53: 133-139.
1342. Koberle B, Masters JR, Hartley JA,
Wood RD (1999). Defective repair of cisplatin-induced
DNA damage caused by
reduced XPA protein in testicular germ cell
tumours. Curr Biol 9: 273-276.
1343. Kochevar J (1984). Adenocarcinoid
tumor, goblet cell type, arising in a
ureteroileal conduit: a case report. J Urol
131: 957-959.
1344. Koeneman KS, Pan CX, Jin JK, Pyle
JM3rd, Flanigan RC, Shankey TV, Diaz MO
(1998). Telomerase activity, telomere
length, and DNA ploidy in prostatic intraepithelial
neoplasia (PIN). J Urol 160: 1533-
1539.
1345. Koide O, Iwai S, Baba K, Iri H (1987).
Identification of testicular atypical germ
cells by an immunohistochemical technique
for placental alkaline phosphatase.
Cancer 60: 1325-1330.
1346. Koide O, Matsuzaka K, Tanaka Y
(1998). Multiple giant angiomyolipomas
with a polygonal epithelioid cell component
in tuberous sclerosis: an autopsy
case report. Pathol Int 48: 998-1002.
1347. Kojima S, Mine M, Sekine H (1998).
[Small cell carcinoma of the kidney. A case
report]. Nippon Hinyokika Gakkai Zasshi
89: 614-617.
1348. Kolonel LN (1996). Nutrition and
prostate cancer. Cancer Causes Control 7:
83-94.
1349. Komatsu H, Tanabe N, Kubodera S,
Maezawa H, Ueno A (1997). The role of
lymphadenectomy in the treatment of transitional
cell carcinoma of the upper urinary
tract. J Urol 157: 1622-1624.
1350. Kommoss F, Bibbo M, Talerman A
(1990). Nuclear deoxyribonucleic acid content
(ploidy) of endodermal sinus (yolk sac)
tumor. Lab Invest 62: 223-231.
1351. Kondoh G, Murata Y, Aozasa K,
Yutsudo M, Hakura A (1991). Very high incidence
of germ cell tumorigenesis (seminomagenesis)
in human papillomavirus type
16 transgenic mice. J Virol 65: 3335-3339.
1352. Konno N, Mori M, Kurooka Y,
Kameyama S, Homma Y, Moriyama N,
Tajima A, Murayama T, Kawabe K (1997).
Carcinosarcoma in the region of the
female urethra. Int J Urol 4: 229-231.
1353. Koochekpour S, Jeffers M, Wang PH,
Gong C, Taylor GA, Roessler LM, Stearman
R, Vasselli JR, Stetler-Stevenson WG,
Kaelin WGJr, Linehan WM, Klausner RD,
Gnarra JR, Vande Woude GF (1999). The
von Hippel-Lindau tumor suppressor gene
inhibits hepatocyte growth factor/scatter
factor-induced invasion and branching
morphogenesis in renal carcinoma cells.
Mol Cell Biol 19: 5902-5912.
1354. Koolen MI, Schipper P, Liebergen FJ,
Kurstjens RM, Unnik AJ, Bogman MJ
(1988). Non-Hodgkin lymphoma with
unique localization in the kidneys presenting
with acute renal failure. Clin Nephrol
29: 41-46.
1355. Koolen MI, van der Meyden AP,
Bodmer D, Eleveld M, van der Looij E,
Brunner H, Smits A, van den Berg E,
Smeets D, Geurts van Kessel A (1998). A
familial case of renal cell carcinoma and a
t(2;3) chromosome translocation. Kidney
Int 53: 273-275.
1356. Kopf AW, Bart RS (1981). Tumor conference
#38. Lymphangioma of the scrotum
and penis. J Dermatol Surg Oncol 7: 870-
872.
1357. Koraitim M, Kamal B, Metwalli N,
Zaky Y (1995). Transurethral ultrasonographic
assessment of bladder carcinoma:
its value and limitation. J Urol 154: 375-378.
1358. Korkolopoulou P, Christodoulou P,
Kapralos P, Exarchakos M, Bisbiroula A,
Hadjiyannakis M, Georgountzos C,
Thomas-Tsagli E (1997). The role of p53,
MDM2 and c-erb B-2 oncoproteins, epidermal
growth factor receptor and proliferation
markers in the prognosis of urinary
bladder cancer. Pathol Res Pract 193: 767-
775.
1359. Korkolopoulou P, Christodoulou P,
Konstantinidou AE, Thomas-Tsagli E,
Kapralos P, Davaris P (2000). Cell cycle
regulators in bladder cancer: a multivariate
survival study with emphasis on
p27Kip1. Hum Pathol 31: 751-760.
326 References